The scarcity of efficient imaging technologies for precise cancer treatment greatly drives the
development of new nanotheranostic based platforms that enable both diagnostic and …

Fluorescent theranostics probes at the second near-IR region (NIR-II; 1.0–1.7 µm) are in
high demand for precise theranostics that minimize autofluorescence, reduce photon …

Second near‐infrared window (NIR‐II, 1000− 1700 nm) fluorescence imaging (FI) in
phototheranostics benefits from deep tissue penetration, negligible body spontaneous …

Fluorescence imaging with deep penetration and low auto-fluorescence in the second near-
infrared biochannel (NIR-II, 1000–1700 nm) was developed rapidly during the past decades …

Over the past two decades, the rapid development of versatile inorganic/organic
fluorophores or biomaterials in the second near-infrared (NIR-II) window (1000− 1700 nm) …

Biomedical fluorescence imaging in the second near-infrared (NIR-II, 100–1700 nm) window
provides great potential for visualizing physiological and pathological processes, owing to …

Background: In vivo fluorescence imaging in the second near-infrared (NIR-II, 1000–1700
nm) window using organic fluorophores has great advantages, but generally suffers from a …

NIR-II (1000–1700 nm) fluorescence imaging is continually attracting strong research
interest. However, current NIR-II imaging materials are limited to small molecules with fast …

Near-infrared (NIR, 650–1700 nm) bioimaging has emerged as a powerful strategy in tumor
diagnosis. In particular, NIR-I fluorescence imaging (650–950 nm) has drawn more …

Near-infrared (NIR) fluorophores have unique features that endow them with several
advantages over conventional shorter wavelength emitting dyes. As a result, they have been …